These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18600016)

  • 41. Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Zheng M; Chen Y; Bai J; Xin Y; Pan X; Zhao L
    Pancreas; 2008 Oct; 37(3):247-53. PubMed ID: 18815544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
    Choi CW; Kang DH; Kim GH; Eum JS; Lee SM; Song GA; Kim DU; Kim ID; Cho M
    Gastrointest Endosc; 2009 Apr; 69(4):e11-8. PubMed ID: 19327467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of timing on performance of laparoscopic cholecystectomy for acute biliary pancreatitis.
    Prabhu RY; Irpatgire R; Naranje B; Kantharia CV; Bapat RD; Supe AN
    Trop Gastroenterol; 2009; 30(2):113-5. PubMed ID: 19761000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Informed consent in vaccination in India: medicolegal aspects.
    Rajput M; Sharma L
    Hum Vaccin; 2011 Jul; 7(7):723-7. PubMed ID: 21743294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activities in a social networking-based discussion group by endoscopic retrograde cholangiopancreatography doctors.
    Kang X; Zhao L; Liu N; Wang X; Zhang R; Liu Z; Liang S; Yao S; Tao Q; Jia H; Pan Y; Guo X
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1131-1135. PubMed ID: 28704223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Informed consent for gastrointestinal endoscopy: a view of endoscopists in Croatia.
    Banic M; Kardum D; Plesko S; Petrovecki M; Urek M; Babic Z; Kujundzic M; Rotkvic I
    Dig Dis; 2008; 26(1):66-70. PubMed ID: 18600019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Endoscopic retrograde cholangiopancreatography: is it possible to effectively prevent ERCP-induced pancreatitis?].
    Il'chenko AA
    Eksp Klin Gastroenterol; 2008; (3):62-71. PubMed ID: 19145885
    [No Abstract]   [Full Text] [Related]  

  • 48. Validation of the X-Vision ERCP Training System and technical challenges during early training of sphincterotomy.
    von Delius S; Thies P; Meining A; Wagenpfeil S; Burian M; Huber W; Weidenbach H; Ebert MP; Neu B; Ludwig L; Almeida J; Prinz C; Schmid RM; Frimberger E
    Clin Gastroenterol Hepatol; 2009 Apr; 7(4):389-96. PubMed ID: 19049832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selected treatments for duodenal perforation after ERCP. A report of three cases.
    Amodio PM; Faggiani R; Pastorelli A; Bigonzoni E; Consolo S; Bruni V; Goglia A; Piccioni E; Piciollo M; Anti M; Palmieri RM
    Chir Ital; 2007; 59(3):343-6. PubMed ID: 17663374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines.
    Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB
    JOP; 2008 Jul; 9(4):456-67. PubMed ID: 18648137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of chronic pancreatitis in the pediatric patient: endoscopic retrograde cholangiopancreatography vs operative therapy.
    Iqbal CW; Moir CR; Ishitani MB
    J Pediatr Surg; 2009 Jan; 44(1):139-43; discussion 143. PubMed ID: 19159731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis.
    Dai HF; Wang XW; Zhao K
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):11-6. PubMed ID: 19208508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adverse outcomes of endoscopic retrograde cholangiopancreatography: avoidance and management.
    Freeman ML
    Gastrointest Endosc Clin N Am; 2003 Oct; 13(4):775-98, xi. PubMed ID: 14986798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Bai Y; Gao J; Zou DW; Li ZS
    Pancreas; 2008 Oct; 37(3):241-6. PubMed ID: 18815543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endoscopic retrograde cholangiopancreatography gut perforations: when to wait! When to operate!
    Morgan KA; Fontenot BB; Ruddy JM; Mickey S; Adams DB
    Am Surg; 2009 Jun; 75(6):477-83; discussion 483-4. PubMed ID: 19545095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infectious complications following endoscopic retrograde cholangiopancreatography: an automated surveillance system for detecting postprocedure bacteremia.
    Anderson DJ; Shimpi RA; McDonald JR; Branch MS; Kanafani ZA; Harger J; Ely TM; Sexton DJ; Kaye KS
    Am J Infect Control; 2008 Oct; 36(8):592-4. PubMed ID: 18926314
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Duodenal perforation post-ERCP: diagnostically and therapeutic management].
    Fattori L; Nespoli L; Ardito A; Germini A; Nespoli A
    Ann Ital Chir; 2007; 78(3):193-4. PubMed ID: 17722492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survey of informed consent for endoscopic retrograde cholangiopancreatography.
    Newton J; Hawes R; Jamidar P; Harig J; Lehman G
    Dig Dis Sci; 1994 Aug; 39(8):1714-8. PubMed ID: 8050323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ERCP complication rates: how low can we go?
    Ryan ME
    Gastrointest Endosc; 2009 Jul; 70(1):89-91. PubMed ID: 19559833
    [No Abstract]   [Full Text] [Related]  

  • 60. Consent, common adverse events, and post-adverse event actions in endoscopy.
    Adler DG
    Gastrointest Endosc Clin N Am; 2015 Jan; 25(1):1-8. PubMed ID: 25442954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.